Skip to main content
Nanobiotix logo

Nanobiotix — Investor Relations & Filings

Ticker · NANO ISIN · FR0011341205 LEI · 969500667RSYIH8YL895 PA Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2014-03-20 Share Issue/Capital Cha…
Country FR France
Listing PA NANO

About Nanobiotix

https://www.nanobiotix.com/

Nanobiotix is a late-stage clinical biotechnology company pioneering a physics-based approach to cancer treatment through the development of nanotherapeutics. Its lead product candidate, NBTXR3, is a potential first-in-class radioenhancer designed to be injected directly into a tumor. When activated by radiotherapy, NBTXR3 amplifies the radiation dose within the tumor, aiming to destroy cancer cells more effectively without increasing exposure to surrounding healthy tissues. This process is also intended to prime an immune response to target metastatic tumors. The company is developing NBTXR3 for broad application across various solid tumors, with an initial focus on head, neck, and lung cancers through a global licensing agreement with Janssen Pharmaceutica NV.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated March 20, 2014, announcing the 'Très vif succès de l'augmentation de capital' (Very strong success of the capital increase) by NANOBIOTIX, raising 28.1 million euros. It details the subscription rate (181%), the creation of new shares, and the intended use of funds (financing product development). This content directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report publication (RPA), as it contains the substantive details of the financing event itself.
2014-03-20 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document explicitly states it is an 'Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social' (Monthly information relating to the total number of voting rights and shares comprising the share capital), referencing Article 223-16 of the AMF General Regulation. This type of filing reports the total number of shares and voting rights as of a specific date (February 28, 2014). This content directly corresponds to notifications regarding changes in share capital or ownership thresholds, which aligns best with the 'Share Issue/Capital Change' (SHA) category, as it details the composition of the capital structure. Although it is a monthly update, it is a specific regulatory disclosure about the capital base, not a general regulatory announcement (RNS) or a director's dealing (DIRS). It is not a dividend notice (DIV) or a major shareholding notification (MRQ) which usually reports a specific threshold crossing by an external party, but rather a mandatory disclosure by the company about its own capital structure.
2014-03-05 French
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Share Issue/Capital Change Classification · 99% confidence The document is an official announcement dated February 20, 2014, detailing the terms of a capital increase ('Augmentation de capital') involving the issuance of new shares via a rights offering ('maintien du droit préférentiel de souscription des actionnaires'). It specifies the subscription period, price, and the intended use of proceeds (financing NBTXR3 development). This clearly falls under corporate financing activities. The document also mentions a prospectus visaed by the AMF (Autorité des marchés financiers). Since the core subject is the fundraising/capital structure change, the most appropriate code is 'CAP' (Capital/Financing Update). It is not a full 10-K, an ER (which is usually just results highlights), or an RPA (as it contains the full details of the offering, not just an announcement that a report is available).
2014-02-20 French
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated February 13, 2014, from NANOBIOTIX. The headline explicitly states the company's intention to launch a 'capital increase with maintenance of preferential subscription rights' ('augmentation de capital avec maintien du droit préférentiel de souscription') to finance development. This action directly relates to fundraising, financing activities, and changes in capital structure. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not an earnings release (ER), an annual report (10-K), or a general regulatory filing (RNS), as it describes a specific corporate finance event.
2014-02-13 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document explicitly states it is an 'Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social' (Monthly information relating to the total number of voting rights and shares comprising the share capital), referencing Article 223-16 of the AMF General Regulation. It provides a table detailing the total number of shares and voting rights as of January 31, 2014. This type of regular disclosure regarding the share capital structure and voting rights is a specific regulatory filing requirement in France, often related to major shareholdings or capital changes, but the most precise fit among the provided codes for a notification about the total number of shares and voting rights is related to share capital changes or major holdings. Since it is a monthly update on the total number of shares and voting rights, it directly relates to the composition of the share capital. While 'SHA' (Share Issue/Capital Change) is related, the specific nature of reporting total voting rights monthly often falls under notifications related to significant ownership thresholds or capital structure transparency. Given the options, this is a mandatory regulatory disclosure concerning the share base. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a specific regulatory disclosure about the share count. This aligns best with either 'SHA' (Share Issue/Capital Change) or 'MRQ' (Major Shareholding Notification) if the threshold crossing is implied, or 'RNS' (Regulatory Filings) as a general catch-all. However, since it is a direct report on the total number of shares and voting rights, which is a key component of capital structure reporting, 'SHA' is a strong candidate, although 'RNS' is often used for these specific AMF disclosures when a more precise code isn't available. Given the content is purely about the total share count and voting rights, it is a fundamental capital structure update. I will classify it as 'SHA' as it reports on the total capital structure, or 'RNS' as a general regulatory filing. Since the document is a direct report of the capital structure data, not an announcement *about* a report, I will lean towards the most relevant structural change category, 'SHA', or the general regulatory filing 'RNS'. Because it is a mandatory monthly disclosure of the total share count, which underpins all share-related transactions, 'RNS' (Regulatory Filings) is the safest and most common classification for these specific AMF capital structure updates when they don't explicitly announce a new issue or buyback, but rather report the current state. I will use RNS as the fallback for specific, non-standard regulatory disclosures.
2014-02-06 French
Communicated under the obligation to provide permanent information / Communication relating to accounts, results, and turnover
Earnings Release Classification · 96% confidence The document explicitly announces the '2013 Annual revenues' as of December 31, 2013, presenting key financial tables for the full year and the fourth quarter. It also mentions the 'Next financial release – 2013 annual results on April 12, 2014'. While it contains annual revenue figures, it is a press release announcing these figures, not the comprehensive 10-K filing itself. The content focuses on summarizing the financial performance for the period and providing business updates, which aligns closely with an Earnings Release (ER). However, since it covers the full year (Annual revenues) and is more detailed than a typical quarterly earnings highlight, it could also be considered a precursor to the full Annual Report (10-K). Given the structure—a press release format detailing annual revenue figures and business highlights—it best fits the Earnings Release (ER) category, which covers periodical financial results announcements. It is not the full 10-K, nor is it a simple announcement of a report (RPA). FY 2013
2014-02-03 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.